NCT00130910View on ClinicalTrials.gov

Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation

NACompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

June 30, 2007

Conditions
HIV InfectionsHelminthiasis
Interventions
DRUG

Albendazole

Albendazole 400mg x 3 first dose observed

DRUG

Placebo

Albendazole Placebo 400mg x 3 first dose observed

Trial Locations (1)

Unknown

Kenya Medical Research Institute, Nairobi

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

University of Nairobi

OTHER

collaborator

Kenyatta National Hospital

OTHER_GOV

lead

University of Washington

OTHER

NCT00130910 - Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation | Biotech Hunter | Biotech Hunter